Global Antimicrobial Wound Dressing Market Expansion to be Persistent During 2018 – 2026

Press Release

Skin and Soft Tissue Infections (SSTIs) are one of the reason for high rate of morbidity and mortality. Even, in the cases of successful surgeries, affected subcutaneous tissue, fascia, or muscle; remains a delay in the healing process and can lead to life-threatening conditions. This cases are propelling demand for more effective treatments to deal with such pathological situations. Recently, wound dressings loaded with antimicrobial agents has emerged as potential option to reduce wound bacterial colonization and infection to improve the healing process.

Get Exclusive Sample Report at:

Antimicrobial wound dressing contains drugs such as antimicrobial agents, biologics such as growth factors, or they are composed of materials derived from animal sources. These dressings prevent bacterial penetration into the wound and avoid growth of microorganisms. The commonly encountered antiseptic agents in the antimicrobial dressings are silver, iodine, chlorhexidine, Polyhexamethylbiguanide (PHMB), alginate, and hydrocolloids.

Antimicrobial Wound Dressing Market Drivers

Conventional wound dressings take longer time for wound healing as compared to advanced wound dressing products such as antimicrobial and anti-infective wound dressings, which are widely used in post-operation to prevent risk of any Hospital Acquired Infections (HAIs). Antimicrobial wound dressings are rapidly replacing conventional wound dressings due to their high functional efficiency and effectiveness.

Increasing incidence of burns, trauma wounds and injuries, and diabetic ulcers are expected to drive growth of the global antimicrobial wound dressings market over the forecast period. For instance, in January 2017, according to the World Health Organization (WHO) data published in African Journal of Emergency Medicines, burn cases accounted for around 18 million disability cases and more than 2,50,000 deaths annually, out of which over 90% deaths were reported in low- and middle-income economies. The U.S. fire department responded to around 1.3 million fire incidences in 2016, out of which 3,280 civilian deaths and 15,700 civilian injuries were reported by National Fire Protection Association (NFPA).

Antimicrobial Wound Dressing Market Restraints

Challenges in classification of antimicrobial wound dressing into the FDA’s existing medical device classification is expected to create further complications in the marketing and gaining the regulatory product approval for antimicrobial wound products. In September 2016, U.S. Food and Drug Administration (FDA) assembled the advisory panel to receive recommendations regarding the appropriate regulatory classification for wound dressings containing drugs.

Antimicrobial Wound Dressing Market – Regional Analysis

Geographically, the market is segmented into North America, Latin America, Europe, Middle East, Asia Pacific, and Africa. North America antimicrobial wound dressing market is expected to offer lucrative growth opportunities in near future, owing to presence of various key players in these market, increasing adoption of antimicrobial wound dressing product by patients and healthcare professionals combined with growing incidence of trauma, wound injuries, and ulcers cases in these region. For instance, the Agency for Healthcare Research & Quality (AHRQ) estimated that, over 2.5 million people in the U.S. develop pressure ulcers annually.

Download PDF Brochure Of This Research Report @

Antimicrobial Wound Dressing Market – Competitor

Some of the key players operating in the market include Smith & Nephew plc. ConvaTec Group plc. Medtronic plc. (Covidien plc.), Acelity L.P. Inc. (Kinetic Concepts, Inc.), Coloplast A/S, Mölnlycke Health Care, B. Braun Melsungen AG, and Paul Hartmann AG.